TD-0903 for ALI Associated With COVID-19

Clinical trial NCT04402866 · COMPLETED

Trial details

NCT number: NCT04402866
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lung Injury (ALI) Associated With COVID-19 Lung Inflammation Associated With COVID-19

Start date: 2020-06-24
Primary completion: 2021-04-21
Enrollment: 235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.